Company intelligence / Profile preview
Viola
Ukraineviolapharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Viola is among the top 10 domestic pharmaceutical manufacturers in Ukraine, producing over 400+ medicines and parapharmaceuticals under certified GMP and ISO standards. The company is rapidly expanding its R&D laboratory and pipeline, focusing on modern generic drugs and complex treatment approaches. Viola's product portfolio includes pain relievers, topical antifungals, antiseptics, and supplements, with an active program for bringing new generics and medicinal forms to market.
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Genom
Beyond the preview
Go deeper on Viola.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Viola.